Literature DB >> 14609186

Different expressions of X-linked cardiomyopathy in monozygotic triplets with Becker's dystrophy.

Lukasz Chrzanowski1, Jaroslaw D Kasprzak, Ewa Trzos, Konrad Wasikowski, Jaroslaw Drozdz, Barbara Ryniewicz, Maria Krzeminska-Pakula.   

Abstract

Cardiac involvement is common in skeletal muscles disorders associated with dystrophin defect. It has been suggested however, that X-linked dilated cardiomyopathies with minimal or absent skeletal disease are distinct entities, resulting from mutations in cardiac-specific regions of dystrophin gene. This study presents a unique observation of phenotypic variability in monozygotic triplets with Becker's muscular dystrophy. The expressions of the disease range from severe peripheral myopathy to severe congestive heart failure. No deletion in dystrophin gene was observed and the mechanisms responsible for selective impairment of morphologically and functionally different muscles in three monozygotic siblings remain unclear.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609186     DOI: 10.1023/a:1025824105194

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  7 in total

1.  Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy.

Authors:  R Ortiz-Lopez; H Li; J Su; V Goytia; J A Towbin
Journal:  Circulation       Date:  1997-05-20       Impact factor: 29.690

2.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

3.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.

Authors:  F Muntoni; M Cau; A Ganau; R Congiu; G Arvedi; A Mateddu; M G Marrosu; C Cianchetti; G Realdi; A Cao
Journal:  N Engl J Med       Date:  1993-09-23       Impact factor: 91.245

4.  Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy.

Authors:  F Muntoni; A Di Lenarda; M Porcu; G Sinagra; A Mateddu; G Marrosu; A Ferlini; M Cau; J Milasin; M A Melis; M G Marrosu; C Cianchetti; A Sanna; A Falaschi; F Camerini; M Giacca; L Mestroni
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

Review 5.  Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; P Morbini; B Dal Bello; N Banchieri; A Pilotto; F Magani; M Grasso; J Narula; A Gavazzi; M Viganò; L Tavazzi
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

6.  X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.

Authors:  J A Towbin; J F Hejtmancik; P Brink; B Gelb; X M Zhu; J S Chamberlain; E R McCabe; M Swift
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

7.  Cardiac involvement in Becker muscular dystrophy.

Authors:  P Melacini; M Fanin; G A Danieli; G Fasoli; C Villanova; C Angelini; L Vitiello; M Miorelli; G F Buja; M L Mostacciuolo
Journal:  J Am Coll Cardiol       Date:  1993-12       Impact factor: 24.094

  7 in total
  1 in total

Review 1.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.